Nurse Practitioner in Murphys, CA Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Jeanette Toth, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 300 Church Street, Murphys, CA 95247 Phone: 209-728-2021 Fax: 209-728-8752 |
News Archive
Majority of physicians utilize genetic testing, finds report
A new report by UnitedHealth Group's Center for Health Reform & Modernization finds that a majority of physicians are utilizing genetic testing. The report, titled "Personalized Medicine: Trends and prospects for the new science of genetic testing and molecular diagnostics," presents new findings on how genetic tests can help diagnose disease, target prevention, and ensure that patients receive the medicines that will best treat their conditions.
NIAMS scientific director to receive 2014 Ross Prize in Molecular Medicine
John J. O'Shea, M.D., scientific director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), has been named the 2014 recipient of the Ross Prize in Molecular Medicine, conferred by the Feinstein Institute's peer-reviewed, open-access journal Molecular Medicine.
DURECT commences dosing in its POSIDUR Phase III clinical trial
DURECT Corporation announced today that it has begun dosing patients in its U.S. pivotal Phase III clinical trial to evaluate POSIDUR™ (SABER™-Bupivacaine), an investigational drug, for the treatment of post-surgical pain. The pivotal trial, referred to as BESST (Bupivacaine Effectiveness and Safety in SABER Trial), is an international, multi-center, randomized, double-blind, controlled trial evaluating the safety, efficacy, effectiveness, and pharmacokinetics of POSIDUR in patients undergoing general surgical procedures.
After son's death, Virginia official vows to help change state's mental health system
Former gubernatorial candidate Creigh Deeds, who was stabbed repeatedly by his son before the young man took his own life, says, "I am alive for a reason and I will work for change."
BioMimetic completes 100 day PMA meeting with FDA for Augment Bone Graft
BioMimetic Therapeutics, Inc. today announced it completed its 100 day Premarket Approval Application (PMA) meeting with the Food and Drug Administration (FDA) regarding the review of Augment™ Bone Graft for the treatment of foot and ankle fusions in the U.S. The FDA generally meets with the PMA sponsor approximately 100 days after the filing of the PMA with the purpose of discussing the status of the application.
› Verified 9 days ago